SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-224663
Filing Date
2024-09-24
Accepted
2024-09-24 14:51:56
Documents
8
Period of Report
2024-09-24

Document Format Files

Seq Description Document Type Size
1 6-K d873867d6k.htm 6-K 9603
2 EX-99.1 d873867dex991.htm EX-99.1 42136
3 EX-99.2 d873867dex992.htm EX-99.2 31812
4 EX-99.3 d873867dex993.htm EX-99.3 31359
5 GRAPHIC g873867g0924154045812.jpg GRAPHIC 2512
6 GRAPHIC g873867g0924154414101.jpg GRAPHIC 2601
7 GRAPHIC g873867g0924154812022.jpg GRAPHIC 1087
8 GRAPHIC g873867snap1.jpg GRAPHIC 1283
  Complete submission text file 0001193125-24-224663.txt   127055
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 241319485
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)